Abstract |
The major issues of self-assembled nanoparticles as drug carriers for cancer therapy include biostability and tumor-targetability because the premature drug release from and nonspecific accumulation of the drug-loaded nanoparticles may cause undesirable toxicity to normal organs and lower therapeutic efficacy. In this study, we developed robust and tumor-targeted nanocarriers based on an amphiphilic hyaluronic acid (HA)- polycaprolactone (PCL) block copolymer, in which the HA shell was cross-linked via a bioreducible disulfide linkage. Doxorubicin (DOX), chosen as a model anticancer drug, was effectively encapsulated into the nanoparticles with high drug loading efficiency. The DOX-loaded bioreducible HA nanoparticles (DOX-HA-ss-NPs) greatly retarded the drug release under physiological conditions (pH 7.4), whereas the drug release rate was markedly enhanced in the presence of glutathione, a thiol-containing tripeptide capable of reducing disulfide bonds in the cytoplasm. Furthermore, DOX-HA-ss-NPs could effectively deliver the DOX into the nuclei of SCC7 cells in vitro as well as to tumors in vivo after systemic administration into SCC7 tumor-bearing mice, resulting in improved antitumor efficacy in tumor-bearing mice. Overall, it was demonstrated that bioreducible shell-cross-linked nanoparticles could be used as a potential carrier for cancer therapy.
|
Authors | Hwa Seung Han, Thavasyappan Thambi, Ki Young Choi, Soyoung Son, Hyewon Ko, Min Chang Lee, Dong-Gyu Jo, Yee Soo Chae, Young Mo Kang, Jun Young Lee, Jae Hyung Park |
Journal | Biomacromolecules
(Biomacromolecules)
Vol. 16
Issue 2
Pg. 447-56
(Feb 09 2015)
ISSN: 1526-4602 [Electronic] United States |
PMID | 25565417
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Biocompatible Materials
- Drug Carriers
- Doxorubicin
- Hyaluronic Acid
|
Topics |
- Animals
- Antineoplastic Agents
(administration & dosage, metabolism)
- Biocompatible Materials
(administration & dosage, metabolism)
- Cell Line, Tumor
- Doxorubicin
(administration & dosage, metabolism)
- Drug Carriers
(administration & dosage, metabolism)
- Drug Delivery Systems
(methods)
- Hyaluronic Acid
(administration & dosage, metabolism)
- Mice
- Mice, Nude
- NIH 3T3 Cells
- Nanoparticles
(administration & dosage, metabolism)
- Neoplasms
(drug therapy, metabolism)
- Xenograft Model Antitumor Assays
(methods)
|